Medtronic’s SCD-HeFT
This article was originally published in The Gray Sheet
Executive Summary
Sudden Cardiac Death in Heart Failure Trial completes follow-up phase with minimum of 30 months and average of 40 months follow-up, the firm says. Results are slated for release in the first quarter of 2004. The 2,521-patient trial, begun in 1997, compares ICD-implanted patient arrhythmia and mortality rates with drug and placebo arms in moderate heart failure patients at high risk for sudden cardiac arrest (1"The Gray Sheet" Feb. 17, 2003, p. 6)...